Sue Desmond-Hellmann

Sue Desmond-Hellmann
Born1958 (age 66–67)
Napa, California, U.S.
EducationUniversity of Nevada, Reno (BS, MD)
University of California, Berkeley (MPH)
External audio
“Pandemic Perspectives: Interview with Sue Desmond-Hellmann”, May 14, 2020, Science History Institute.

Sue Desmond-Hellmann (born 1958) is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.